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Abstract
Background: Colorectal carcinomas (CRC) carry massive genetic and transcriptional alterations that influence
multiple cellular pathways. The study of proteins whose loss-of-function (LOF) alters the growth of CRC cells can be
used to further understand the cellular processes cancer cells depend upon for survival.
Results: A small-scale RNAi screen of ~400 genes conducted in SW480 CRC cells identified several candidate genes
as required for the viability of CRC cells, most prominently CASP8AP2/FLASH. To understand the function of this
gene in maintaining the viability of CRC cells in an unbiased manner, we generated gene specific expression
profiles following RNAi. Silencing of CASP8AP2/FLASH resulted in altered expression of over 2500 genes enriched for
genes associated with cellular growth and proliferation. Loss of CASP8AP2/FLASH function was significantly
associated with altered transcription of the genes encoding the replication-dependent histone proteins as a result
of the expression of the non-canonical polyA variants of these transcripts. Silencing of CASP8AP2/FLASH also
mediated enrichment of changes in the expression of targets of the NFB and MYC transcription factors. These
findings were confirmed by whole transcriptome analysis of CASP8AP2/FLASH silenced cells at multiple time points.
Finally, we identified and validated that CASP8AP2/FLASH LOF increases the expression of neurofilament heavy
polypeptide (NEFH), a protein recently linked to regulation of the AKT1/ß-catenin pathway.
Conclusions: We have used unbiased RNAi based approaches to identify and characterize the function of
CASP8AP2/FLASH, a protein not previously reported as required for cell survival. This study further defines the role
CASP8AP2/FLASH plays in the regulating expression of the replication-dependent histones and shows that its LOF
results in broad and reproducible effects on the transcriptome of colorectal cancer cells including the induction of
expression of the recently described tumor suppressor gene NEFH.
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Cancer cells are characterized by changes in proteins
that favor cell survival and proliferation, including
down-regulation or de-activation of pro-apoptotic fac-
tors and cell cycle regulators, and up-regulation or acti-
vation of anti-apoptotic factors including kinases and
growth factors. Targeting of specific proteins to over-
come or bypass this suppression of cell death and
enhancement of proliferation is a major approach for
the development of anti-cancer therapies. Like all can-
cers, colorectal cancer is marked by genomic aberrations
and transcriptional deregulation that affect multiple cel-
lular pathways [1]. The characterization of proteins
whose function alters the underlying molecular features
of CRC has the potential to identify new therapeutic
strategies for CRC. Gene-specific loss-of-function (LOF)
analysis, through the application of RNA interference
(RNAi) based technologies, is increasingly being used to
probe the role of a particular protein in a specific cellu-
lar context [2].
We have recently used RNAi based LOF approaches
to validate the functional dependence of colorectal can-
cer cells on genes identified as over-expressed in CRC
[3]. Loss-of-function analysis via RNAi can also be used
to identify proteins required for the survival of CRC
cells that show no significant genomic or transcriptional
changes. Alterations in apoptosis and related survival
mechanisms contribute to both the development of
CRC, and the response to treatment [4]. For example,
colorectal tumors often show increased expression of
members of the anti-apoptotic BCL family including
BCL2, mutations in the tumor suppressor TP53, and
defects in several pathways related to inflammation
including the COX2, TGF-ß, and NFB pathways. It is
likely that many less well-characterized proteins related
to cell survival alter the growth of CRC cells. Identifica-
tion of such genes could though give further insight into
the molecular changes underlying CRC, and thus the
development of new treatment strategies. To assess the
feasibility of identifying proteins whose function has not
previously been identified as essential for the survival of
colorectal cancer cells we conducted a small-scale RNAi
screen of ~400 genes in CRC cells. The gene targets
were focused on proteins associated with cell survival,
with an emphasis on regulators, and effectors of apopto-
sis. One of the candidate genes most prominently
required for the survival of CRC cells was the gene
encoding Caspase-8-Associated Protein 2 or FLICE-
associated Huge Protein (CASP8AP2/FLASH). Subse-
quent whole transcriptome profiling showed that CAS-
P8AP2/FLASH LOF has wide-ranging, and specific,
effects on gene expression including deregulated expres-
sion of the replication-dependent histone genes.
Methods
Cell Culture and siRNA transfections
SW480 (an aneuploid, mismatch-repair proficient, colon
adenocarcinoma cell line), SW837 (an aneuploid, mis-
match repair proficient, rectal adenocarcinoma cell line),
and SW48 (a mismatch-repair deficient, diploid, colon
adenocarcinoma cell line) cells were obtained from
ATCC (Manassas, VA) and were maintained in RPMI
(Invitrogen, Carlsbad, CA) containing 10% fetal bovine
serum (FBS, Invitrogen), supplemented with L-Gluta-
mine and penicillin/streptomycin, at 37°C in a humidi-
fied atmosphere containing 5% CO2.C e l l sw e r e
passaged every four to five days. The choice of SW480
as the cell line for the RNAi screen was based on char-
acteristics of the spectral karyotype that recapitulate
chromosomal aberrations commonly observed in color-
ectal cancer [3]. The synthetic siRNA based RNAi
screen was performed using the Human Apoptosis Set
Library (Qiagen, Valencia, CA) arrayed in a total of ele-
ven 96 well plates, one siRNA per well. Gene targets
were selected based on searches of the PANTHER (Pro-
tein ANalysis THrough Evolutionary Relationships)
Classification System, the Gene Ontology database, and
PubMed resources (E. Lader, Qiagen, Personnel commu-
nication). See Additional file 1, Table S1 for list of genes
targeted and siRNA target sequences. Genes targeted
included known regulators and effectors of apoptosis,
proteins with less defined functions in cell survival and
apoptosis and a few proteins with no known direct func-
tion linked to apoptosis so all functional groups were
represented. We have previously determined successful
transfection conditions of siRNAs into SW480 cells
using the Oligofectamine transfection reagent (Invitro-
gen) [3]. We confirmed these conditions for this study
by examining the silencing of the CTNNB1 gene at an
mRNA level (Additional file 2, Figure S1A) and the via-
bility of SW480 cells following silencing of Polo-like
kinase 1 (PLK1) (Additional file 2, Figure S1B). The
RNAi screen was conducted as follows; transfections
were performed by pre-complexing siRNA (2 pmol)
with 0.6 μl Oligofectamine lipid transfection reagent
(Invitrogen) in 50 μL of serum free RPMI in individual
plate wells for 30 min at ambient temperature. Next,
SW480 cells (7,000) were added in 50 μL RPMI supple-
mented with 20% FBS to yield a final concentration of
20 nM siRNA in RPMI, 10% FBS. This final mixture
was incubated at ambient temperature for 1 hour before
being placed at 37°C in a humidified atmosphere con-
taining 5% CO2. After 72 hours cell viability was assayed
(Cell Titer Blue Reagent, Promega, Madison, WI). As
this was a relatively small-scale siRNA screen, the viabi-
lity of SW480 cells following siRNA transfection was
expressed relative to the average viability for cells
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Negative Control siRNA (siNeg) (Qiagen Inc.) (n = 33)
(Additional file 2, Figure S1C). A siRNA corresponding
to PLK1 was used as a positive control on every plate
(see Additional file 3, Table S2 for sequence); on average
this induced a decrease in the viability of SW480 cells of
greater than 85% (n = 11) (Additional file 2, Figure
S1C). For gene specific analysis SW480, SW48, and
SW837 cells were transfected in 96 well plates as above
using 15,000 SW48 cells, 10,000 SW837 cells, and 5,000
SW480 cells per well. See Additional file 3, Table S2 for
the sequences of gene specific siRNAs. Transfections for
whole transcriptome analysis were performed in tripli-
cate in 6-well plates, using 2.1 × 10
5 SW480 cells and
1.8 μL Oligofectamine per well.
RNA assays
Quantitative reverse transcription-PCR
Total RNA was isolated from cells using the RNeasy
Mini kit (Qiagen) and mRNA reverse transcribed into
cDNA using random hexamer primers or oligo dT and
reverse transcriptase (Invitrogen SuperScriptIII). Gene
expression levels for CASP8AP2/FLASH and NUP62
were assayed by quantitative reverse transcription-PCR
(qRT-PCR) using Power SYBR Green technology
(Applied Biosystems, Inc., Foster City, CA) and were
normalized to the expression of YWHAZ. For each RT-
PCR reaction, 300 ng cDNA was used. PCR was per-
formed using default variables of the Applied Biosys-
tems’ Prism 7000 sequence detector, except for a total
reaction volume of 25 μL. Primers were obtained from
Operon Technologies, Inc. (Huntsville, AL) or Invitro-
gen. Gene expression levels for HIST1H2BD were deter-
mined by oligo-dT or random hexamer primed
synthesis of cDNA (Invitrogen), and real-time PCR
amplification in i-cycler (Bio-Rad) based conditions with
SYBR green. HIST1H2BD expression levels were nor-
malized to the expression of ß-actin. See Additional file
4, Table S3 for all primer sequences.
Branched DNA assay
Quantigene Probes (Panomics, Fremont, CA) corre-
sponding to CASP8AP2/FLASH were used to directly
measure gene specific mRNA levels (normalized to
human cyclophilin B (PPIB) expression) in cell lysates as
previously described [5].
Whole transcriptome analysis
RNA samples were quantified and assessed for quality
on a Bioanalyzer (Agilent, Santa Clara, CA) and only
samples with an RIN value > 8 were hybridized. For
microarray analysis, 700 ng RNA was converted to
cRNA using an oligo dT primer, labeled with Cy3, and
subjected to mono-channel hybridization onto a 4 ×
44K Whole Human Genome Microarray per the manu-
facturers instructions (Agilent). Microarrays were
washed and processed using an Agilent G2565BA scan-
ner. Data were quality controlled and extracted using
Agilent Technologies’ Feature Extraction (version 9.1).
Microarray expression data are available at the Gene
Expression Omnibus (GEO) accession GSE29405 and
are in accordance with MIAME guidelines.
Tumor data: Array CGH and mRNA
The array comparative genomic hybridization (CGH)
and transcriptome analysis of primary colon adenocarci-
noma tumors and cell lines has been previously
described [6,7].
Caspase 8 and Caspase 3/7 assays
The activation of Caspase 8 and Caspase 3/7 were mea-
sured using an Ac-LETD-pNA caspase-8 substrate (Cas-
pase-Glo 8 Assay, Promega) and a DEVD peptide
substrate (Caspase-Glo 3/7 Assay, Promega) respectively,
following the manufacturers instructions. Plates were
measured with a Victor luminometer (Perkin Elmer) at
60 min after addition of the Caspase 8 reagents and 90
min after the addition of the Caspase 3/7 reagents.
Western blot analysis
Transfections for Western blot analyses were performed
in 6-well plates, using 1.8 × 10
5 SW480 cells and 10.5
μL RNAiMax per well. Whole cell lysates were har-
vested from SW480 cells 72 hours post transfection
with siCASP8AP2.3 and siCASP8AP2.6 according to the
Complete Lysis-M Reagent Kit (Roche, Indianapolis,
IN). Reduction of CASP8AP2/FLASH mRNA was
assessed by RT-PCR from replicate samples. Soluble
protein fractions were run on a 10% SDS-PAGE gel and
transferred to nitrocellulose membrane for 1 hour at 12
V with an additional 30 minutes at 24 V. The mem-
brane was incubated with a-actin clone C4 (1:1000 dilu-
tion) (Millipore, Temecula, CA) and a-200 kD
Neurofilament Heavy - Neuronal Marker (1:1000 dilu-
tion) (Abcam, Cambridge, MA) in 10% milk buffer in
1× PBS on a rocking platform overnight at 4 degrees.
The membrane was washed 3 times for 10 minutes in
10% milk buffer in 1× PBS and incubated with HRP a-
mouse (1:10,000 dilution) (Jackson ImmunoResearch,
West Grove, PA) for 1 hour on a rocking platform at
room temperature. The membrane was washed as
before, rinsed with DI water and incubated with Super-
Signal West Pico Chemiluminescent Substrate (Pierce/
Thermo Fisher Scientific Rockford, IL) according the
protocol. Kodak BioMax Light Film (Carestream Health,
Woodbridge, CT) was used to expose the membrane for
varying amounts of time.
Bioinformatic and statistical analysis
Standard statistical analyses were conducted in Excel.
Comparisons of functional effects of gene silencing were
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≤0.05 was considered significant. Comparison of the fold
change in different gene expression data sets was
assessed using a Pearson’s correlation.
Gene expression microarray data
Gene expression array signal intensities were Log2 trans-
formed and quantile normalized using the R statistical
computing software and the package Limma. Differential
expression between groups was assessed using an
empirical Bayes method for the moderated T-statistics;
all probes were corrected for multiple testing using Ben-
jamini and Hochberg’s false discovery rate (FDR) [8-11].
In order to be considered differentially expressed, probes
had to have an average Log2 fold change of ± 0.6
(approximately 1.5 fold change on a linear scale) and a
q-value (FDR) < 0.05. In addition, probes needed to
show this significant fold change in the same direction
for both siRNAs targeting CASP8AP2/FLASH in the
initial analysis and for all three siRNAs in the follow up
study.
T h et i m ec o u r s es t u d ya l s oi n c l u d e dac o m p a r i s o no f
siNeg transfected cells and untransfected cells. Any
probes showing a significant differential expression (q-
value < 0.05) in the siNeg cells versus untransfected
SW480 cells were filtered from data used for analysis of
gene ontologies, pathway analysis and gene set enrich-
ment analysis. Of the ~44,000 probes examined this
resulted in the removal of just 124 probes from the 24-
hour data set, 820 probes at 48 hours, and ~1500 probes
at 72 hours.
To determine if any genes exhibiting decreased
expression represented interactions between the trans-
fected siRNA and non-targeted transcripts, we assessed
the alignment of each siRNA sequence with the 3’UTR
sequence of all of the downregulated genes obtained fol-
lowing transfection of each siRNA. The open-access
miRanda application http://www.microrna.org was used
to perform alignment predictions between each siRNA
sequence and the 3’UTR sequence for all genes that
showed decreased expression with each siRNA. We then
examined in detail the non-targeted genes that were
downregulated by two or more siRNAs that showed a
potential miRNA-like mismatch alignment with a
sequence within the 3’UTR of the non-targeted gene.
One-way hierarchical clustering (average linkage) of
the gene profiles was conducted on the expression data
using JMP 8.0 (SAS, Cary, NC).
Gene expression microarray data analysis: Histone genes
The sequences of the 60 nucleotide probes (Agilent)
annotated as corresponding to 79 human histone genes
were all reassessed for alignment to the current RNA
reference sequence (refseq_rna) database using nBLAST
(Megablast, optimized for highly similar sequences) to
confirm specificity and annotation. As described in
Gertz et al., we confirmed high quality alignments
between a probe and a gene as requiring a BLAST score
of at least 100 bits [12]. Most probes corresponded to
unique histone transcripts and returned scores of 111
bits (the maximum score). Where a probe alignment of
111 bits was returned for more than one gene the anno-
tation was altered to reflect both loci. Probe alignments
to genes other than the principal target gene that
returned scores of between 100 and 110 bits are noted
i nT a b l e1 .P r o b e st h a td i dn o ta l i g nt oac u r r e n tR N A
reference sequence, but were associated with a signifi-
cant fold changes in expression, were also aligned
against the entire NCBI nucleotide collection; the cDNA
clones corresponding to these probes are noted in Table
1. Data corresponding to probes sequences that aligned
to transcripts now annotated as a pseudogene were
excluded.
Ingenuity Pathway Analysis and Gene Set Enrichment
Analysis (GSEA)
Differentially expressed genes (see criteria above) were
analyzed through the use of IPA (Ingenuity
® Systems,
http://www.ingenuity.com). Each dataset was divided
into up- and downregulated genes respectively, and then
was subjected to gene function (gene ontology) analysis.
Enrichment of functional groups within gene sets was
calculated using a one-tailed Fisher’s exact test. Func-
tional groups with a Benjamini-Hochberg (B-H) cor-
rected p-value of < 0.05 were considered significant.
Knowledge-based gene networks were also generated
using IPA tools. A maximum network size of 70 mole-
cules was used. In order to condense datasets for Gene
Set Enrichment Analysis [13], the median value of each
probe (using all siRNA transfections) was normalized to
the median value of the same probe in the mock trans-
fections (siNeg). When two or more probes mapped to
as i n g l eg e n e ,t h em e d i a nn o r m a l i z e de x p r e s s i o nv a l u e
was taken so that each gene mapped to a single expres-
sion value. GSEA was run using default parameters
http://www.broadinstitute.org/gsea/index.jsp. The result-
ing landscape plots were analyzed for peaks in the tails
of the ranked gene lists. FDR q-values < 0.05 were con-
sidered significant.
Transcription factor target gene datasets
Transcription factor target gene lists were derived from
ChIP-Chip, ChiP-PET, or ChIP-seq data curated from
peer-reviewed literature (Additional file 5, Table S4). In
certain instances, other biological assays and techniques
such as gene expression and quantitative ChIP were
used in conjunction with ChIP-Chip, ChIP-PET, or
ChIP-Seq in order to derive higher-confidence lists.
NFB target genes were taken from http://www.bu.edu/
nf-kb/gene-resources/target-genes/ (complied December
2009), which is a compilation of downstream NFkB tar-
gets reported in peer-reviewed literature. All gene lists
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Page 7 of 22were cross-referenced to the Ingenuity Knowledge Base
as well as NCBI Entrez Gene. Genes that could not be
mapped to these databases by their published or asso-
ciated identifiers were excluded.
Results and Discussion
RNAi screening in the colorectal cancer cell line SW480
identifies CASP8AP2/FLASH as required for cell viability
A siRNA based RNAi screen of 405 genes (two siRNAs/
gene), most with annotated functions that include a role
related to apoptosis, was conducted in the colorectal
cancer (CRC) cell line SW480 (see Additional file 2, Fig-
ure S1D for a summary of the screen and Additional file
1, Table S1 for details of genes targeted and the relative
cell viability of SW480 cells following RNAi normalized
to siNegative control transfected cells). The aim of this
screen was to identify genes not previously recognized
as required for the survival of CRC cells. The two siR-
NAs corresponding to 45 genes both induced at least a
25% decrease in cell viability 72 hours post siRNA trans-
fection (Additional file 2, Figure S1E). Of these 45 genes
we selected 15 genes that represented a range of
reduced viability seen in the initial screen for confirma-
tion using the same siRNAs but with transfections con-
ducted in triplicate (Additional file 2, Figure S1F). These
15 genes included BIRC5 (Survivin), silencing of which
would be expected to induce a significant effect on the
growth of SW480 cells [14] and proliferating cell nuclear
antigen (PCNA), an essential protein required for DNA
replication. Of the 15 genes followed up here, both siR-
NAs corresponding to five genes, CASP8AP2/FLASH,
NUP62, NTRK1, WDR3,a n dTRAF1 reproducibly
reduced cell viability by over 50%, levels either compar-
able or more than that seen following silencing of
BIRC5/Survivin and PCNA (Additional file 2, Figure
S1F). At least one further siRNA corresponding to each
of these fives genes was then assessed to confirm the
phenotypic effects seen with the siRNAs used in the
initial screen (Figure 1A). The silencing of CASP8AP2/
FLASH and NUP62 showing the most consistent effect;
an average of 60% reduction in viability was observed in
CASP8AP2/FLASH silenced cells, and an average of 50%
reduction in viability was seen in NUP62 silenced cells.
The numerical values associated with the relative viabi-
lity of the screens fluctuated slightly, reflecting natural
variation in the biological replicate populations of cells
and other subtle experimental factors, however, in every
screen conducted, the reduction of CASP8AP2/FLASH
consistently produced a substantial reduction in viability.
The effect of silencing CASP8AP2/FLASH and NUP62
on cell viability was further enhanced when viability was
assayed up to 144 hours post siRNA transfection (Figure
1B). We confirmed the silencing of CASP8AP2/FLASH
and NUP62 RNA following RNAi by qRT-PCR (Figure
1C and 1D) and a reduction in viability in two further
CRC cell lines. Both siRNAs corresponding to CAS-
P8AP2/FLASH reduced the viability of SW837 and
SW48 cells, though only one siRNA corresponding to
NUP62 induced a reduction in the viability of SW837
and SW48 cells (Figure 1C and 1D).
As the silencing of CASP8AP2/FLASH showed the
most consistent effect on the survival of CRC cells and
has not been studied previously in the context of color-
ectal cancer we chose to examine this gene in further
detail. CASP8AP2/FLASH was initially discovered as
involved in the binding of the FAS-associated adaptor
protein (FADD), and procaspase-8 [15]. Ligand binding
of FAS to the FAS cell surface receptor relays the
extrinsic apoptotic death signal through recruitment of
FADD, procaspase-8 activation, and formation of the
death-inducing signaling complex (DISC). A number of
studies have supported the interaction of CASP8AP2/
FLASH with FADD and as a regulator for activation of
CASPASE 8 [16] and thus apoptosis [17]. However,
other studies have challenged the pro-apoptotic role of
CASP8AP2/FLASH [18] and there is increasing evidence
that the large CASP8AP2/FLASH protein (222 KDa) has
multiple functions. A previous RNAi screen conducted
in HeLa cells identified CASP8AP2/FLASH as essential
for cell division [19] and other studies have linked it to
NFB signaling [20,21], activation of MYB [22,23], S-
phase progression [24-26], and an involvement in his-
tone biology. Evidence for the involvement of CAS-
P8AP2/FLASH in histone biology includes its cellular
location in nuclear organelles found adjacent to histone
genes and biochemical studies linking it to histone tran-
script processing [24,27-32].
Molecular characteristics of CASP8AP2/FLASH in colorectal
cancer
Specific DNA and RNA based alterations are frequently
associated with colorectal cancer. The examination of
data obtained from colorectal cancer cell lines and pri-
mary tumors showed, however, no overt genomic or
expression changes associated with the CASP8AP2/
FLASH ( F i g u r e2 ) .T h eC h r .6 q 1 5r e g i o nc o n t a i n i n g
CASP8AP2/FLASH l o c u ss h o w e dar e d u c t i o ni nc o p y
number compared to normal colon mucosa in four out
of five microsatellite-stable CRC cell lines (SW837,
SW480, HT29, and Colo201) (Figure 2A). Only T84
showed a slight gain and a corresponding increase in
mRNA expression compared to normal colon mucosa
(~2-fold change) (Figure 2B). CAPS8AP2/FLASH expres-
sion is close to normal expression levels in HCT116 and
LoVo cells and slightly increased (1.6 to 1.9-fold change
relative to normal colon mucosa) in the other four cell
lines (Figure 2B). Gene expression of CASP8AP2/FLASH
is less than normal colon mucosa (0.7 linear fold
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Figure 1 RNAi identifies CASP8AP2/FLASH and NUP62 as essential for the viability of SW480 cells. (A) The relative viability of SW480 cells
following transfection of three different siRNAs targeting each of the genes shown (see Methods for the identity of each siRNA). Data is shown as
the mean ± SD of three independent transfections for each siRNA targeting the six genes of interest, normalized to the average viability of SW480
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siPLK1, (six independent transfections) is also shown. The statistical comparison (t-test of unequal variance) of siNeg transfected cells to cells
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Page 9 of 22change) in HT29 and SW837 cells, close to normal (1.1
to 1.2 linear fold change) in Colo201, SKCO1, and
SW480 cells, and higher (> 1.3 linear fold change) in the
remaining five cell lines (Figure 2B). CASP8AP2/FLASH
protein expression has been shown to be higher in gas-
tric carcinomas compared with normal tissues [33],
however, expression of CASP8AP2/FLASH in 23 primary
colon adenocarcinoma tumors showed levels close to
that observed in normal colon mucosa (average linear
fold change = 1.103, p = 0.48) (Figure 2C). Only two
samples had expression ratios greater than 1.5, of which
one had a linear fold change of 3.3 compared to normal
mucosa.
Silencing of CASP8AP2/FLASH activates apoptosis
associated markers
To begin to understand the functional processes under-
lying the decrease in the viability of CRC cells seen fol-
lowing silencing of CASP8AP2/FLASH we first assessed
the effect of its LOF had on markers of apoptosis. CAS-
P8AP2/FLASH was originally identified as a pro-apopto-
tic protein involved in FAS-mediated apoptosis. For
example, a previous study showed FAS induced apopto-
sis was significantly reduced following the silencing of
CASP8AP2/FLASH in HT1080 cells [34]. We therefore
hypothesized that, particularly in the absence of activa-
tion of FAS, silencing CASP8AP2/FLASH would have
minimal effect on established markers of the apoptosis
cascade. However, in SW480 cells, 48 hours following
initiation of silencing of CASP8AP2/FLASH, activation
of Caspase 8 was observed (Figure 3Ai; siCASP8AP2.3 p
= 0.0002, siCASP8AP.6 p = 0.001); a significant activa-
tion of Caspase 8 was also observed 72 hours post
siRNA transfection (Figure 3Bi siCASP8AP2.3 p = 0.02,
siCASP8AP.6 p = 0.001. In addition, an activation of the
downstream caspases, Caspase 3 and 7 was observed at
both 48 and 72 hours post-siRNA transfection (Figure
3Aii and 3Bii; 48 hours, siCASP8AP2.3 p = 0.0008,
siCASP8AP.6 p = 0.00001, 72 hours, siCASP8AP2.3 p =
0.001, siCASP8AP.6 p ≤0.00001). At 48 hours Caspase 8
and Caspase 3/7 levels were similar to that seen follow-
ing silencing of a positive control, the Polo like kinase 1
gene, PLK1, whose inhibition is well known to activate
apoptosis [35] and were greater than that seen in PLK1
silenced cells 72 hours post siRNA transfection.
The activation of markers of apoptosis can result from
alterations in many different cellular processes. Further,
because CASP8AP2/FLASH has been linked to multiple
f u n c t i o n sw ec h o s et ou s eas y s t e m s - w i d eu n b i a s e d
approach to investigate the principal downstream effects
that perturbation of CASP8AP2/FLASH function has on
CRC cells.
The CASP8AP2/FLASH loss-of-function induces changes in
the expression of over two thousands genes
To investigate the systems-wide effects of CASP8AP2/
FLASH LOF we conducted whole transcriptome micro-
array analysis of siRNA transfected SW480 cells using
two different siRNAs. Differential expression following
gene silencing was indicated by probes that showed a
fold change in expression of > Log2 ±0 . 6
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Page 10 of 22(corresponding to a linear fold change of ~1.5), with a
q-value (FDR) of < 0.05, for both siRNAs targeting CAS-
P8AP2/FLASH. Overall, there was a high correlation in
the fold change seen for those probes showing a signifi-
cant fold change for both of the siRNAs (siCASP8AP2.3
vs. siCASP8AP2.6 r = 0.97). Only two probes showed a
discordant change in the direction of the fold change
seen with each siRNA (Additional file 6, Figure S2A),
and only one potential off-target interaction within CAS-
P8AP2/FLASH the expression profile was identified
(Additional file 6, Figure S2B). The final gene expression
profile, or RNAi signature, for CASP8AP2/FLASH con-
sisted of over 3500 probes (approximately 2500 genes)
(Figure 4A and Additional file 7, Table S5).
We first examined genes related to the primary anno-
tated function of CASP8AP2/FLASH in the regulation
of the extrinsic apoptotic pathway. While we observed
the functional activation of caspase proteins in SW480
cells following the silencing of CASP8AP2/FLASH,a ta
transcriptional level only CASP7 expression was
increased (~2-fold linear increase). The extrinsic apopto-
tic associated proteins FAS and FASLG were both
AB
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Page 12 of 22modestly upregulated at transcriptional level, but there
was no other obvious link to this function of CAS-
P8AP2/FLASH. Because of the lack of a clears associa-
tion with changes in the expression of proteins
associated with the extrinsic apoptotic we next looked
for the enrichment of genes associated with specific
functional ontologies so as to assess the broad biological
processes perturbed as a result of CASP8AP2/FLASH
LOF. No ontology categories where enriched within the
genes that were downregulated following silencing of
CASP8AP2/FLASH. Many ontologies were though asso-
ciated with the genes that were upregulated following
CASP8AP2/FLASH LOF, including the cancer, cellular
growth and proliferation, cell death and gastrointestinal
disease ontologies (Figure 4B and Additional file 8,
Table S6). Genes associated with the cancer, cell growth
and proliferation, and cell death ontologies, included the
upregulation of several cyclin-dependent kinase inhibi-
tors, specifically CDKN1A (p21; ~2.5-fold linear
increase), CDKN1C (p57
Kip2; ~5-fold linear increase),
CDKN2B (p15; ~2-fold linear increase), and CDKN2D
(p19; ~2-fold linear increase). These cyclin-dependent
kinase inhibitors are all critical negative regulators of
cell cycle. Their up-regulation following silencing of
CASP8AP2/FLASH could therefore be of relevance to
the reduction in cell viability observed in CASP8AP2/
FLASH silenced CRC cells.
As another approach to identify critical cellular net-
works perturbed as a result of CASP8AP2/FLASH LOF
we used Gene Set Enrichment analysis (GSEA) to iden-
tify enrichment for the targets of specific transcription
factors associated with CRC within the large CAS-
P8AP2/FLASH RNAi signature. NFB targets were sig-
nificantly enriched within our list of genes upregulated
after silencing of CASP8AP2/FLASH. Activation of
NFB is most frequently associated with an inhibition of
apoptosis and constitutive activation of NFBh a sb e e n
linked to CRC. Previous studies of CASP8AP2/FLASH
function have shown that inhibition of CASP8AP2/
FLASH expression suppressed TNFa induced activation
of NFB [20,21]. Due to correction for multiple testing
no specific canonical pathways were identified as per-
turbed by LOF of CASP8AP2/FLASH, but dense knowl-
edge-based networks focused on TGFß, GRB2, and TNF
were generated from the CASP8AP2/FLASH RNAi sig-
nature (Additional file 9, Figure S3). This TNF-centered
network within the CASP8AP2/FLASH RNAi signature
(Additional file 9, Figure S3, network 3) suggests that
activation of TNF related signaling following silencing of
CASP8AP2/FLASH may be contributing, at least in part,
to the further up-regulation of the expression of NFB
target genes in SW480 cells.
MYC, a well-known proto-oncogene, is critical to the
proliferation and survival of many cancers [36].
Genomic copy number gains of MYC is observed in
some 50% of colorectal tumors and as a target of ß-cate-
nin/TCF7L2 MYC expression is frequently deregulated
in CRC [1]. Deregulated MYC expression can lead to
activation of some genes and repression of other. Inter-
estingly, we observed that after CASP8AP2/FLASH
LOF, genes that are activated by MYC were repressed,
while conversely genes repressed by MYC were activated
(Figure 4C). This indicates that the transcriptional activ-
ity of MYC is reduced in the absence of CASP8AP2/
FLASH. CASP8AP2/FLASH LOF did not directly induce
differential expression of MYC suggesting that this is a
secondary effect perhaps as a result of changes in pro-
teins responsible for the post-translational modification
of MYC that also regulate MYC activity [37].
The clearest LOF molecular phenotype that could be
related to CASP8AP2/FLASH silencing was, however,
alterations in the expression of the histone genes.
The CASP8AP2/FLASH RNAi signature shows broad
deregulation of histone gene transcription
The most intriguing aspect of the CASP8AP2/FLASH
R N A is i g n a t u r ew a st h eh i g h l ys i g n i f i c a n te n r i c h m e n t
(normalized enrichment score = 2.53; FDR q-value <
0.001) for histone transcripts (Figure 5A). Of the
approximately eighty genes encoding histone proteins,
transcripts corresponding to over half of them showed
altered levels compared to siNeg-transfected cells, in
some cases exhibiting an over twenty-fold linear change
in transcript levels (Table 1). Importantly, all histone
transcripts showing a greatert h a nt w o - f o l dc h a n g ei n
mRNA levels were encoded by a subset of histone genes
known as the replication-dependent histone genes. His-
tone proteins form a critical component of chromosome
architecture and structural alterations. Principally, the
acetylation and deacetylation of lysine residues on his-
tone tails govern many important cellular functions, in
particular transcription. Epigenetic modifications of his-
tone proteins are frequently associated with changes in
expression observed in many cancers. The majority of
the canonical histone proteins are encoded by a family
of over 60 replication-dependent histone genes, most
found in clusters on Chromosomes 1 and 6 [38]. The
principal transcripts expressed from these genes are
uniquely non-polyadenylated, containing instead an evo-
lutionarily conserved 3’ stem-loop sequence that is criti-
cal for regulating the expression and function of histone
proteins. Two further histone transcripts expressed from
genes outside of the main gene clusters can also gener-
ate non-polyadenylated mRNAs; the H2AFX gene that
expresses the DNA damage associated histone protein,
H2AX, [39] and the HIST4H4 gene [38]. Expression of
the mRNAs encoding the canonical histone proteins is
tightly regulated; their expression is rapidly induced at
Hummon et al. Molecular Cancer 2012, 11:1
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Figure 5 Loss of CASP8AP2/FLASH function induces changes in the expression of the replication dependent histone genes.( A)T h e
CASP8AP2/FLASH RNAi signature was subjected to gene set enrichment analysis for 79 annotated human histone genes. A very high positive
correlation was observed indicating a significant enrichment (Normalized enrichment score = 2.53; FDR q-value < 0.001) for deregulation of
transcript levels of the human histone genes following silencing of CASP8AP2/FLASH.( B) Diagrammatic representation of the two annotated
transcript variants of HIST1H2BD and the relative positions of PCR primers used in this study. The primers for the HIST1H2BD variant, NM_138720,
were designed to flank a known splice site within this transcript so is its expression could be assessed by qRT-PCR without the risk of
amplifying genomic DNA. (C) RT-PCR quantification of changes in (i) CASP8AP2/FLASH and (ii) HIST1H2BD expression using cDNA generated
using random hexamer priming. (D) RT-PCR quantification of changes in CASP8AP2/FLASH and HIST1H2BD expression following silencing of
CASP8AP2/FLASH. RNA was harvested 72 hours after silencing of CASP8AP2/FLASH and cDNA generated using either (i) random hexamers or (ii)
oligo dT. Data is shown as the median of two independent cDNA syntheses and two independent PCR reactions per cDNA synthesis.
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Page 14 of 22the beginning of S phase, must remain high throughout
S phase, and then is rapidly degraded at the end of S
phase [40]. The expression and processing of histone
transcripts requires a unique set of proteins including
nuclear protein ataxia telangietasia or NPAT protein,
the U7 small nuclear RNA associated proteins LMS10
and LSM11, and the stem-loop binding protein, SLBP
[40]. A number of recent studies have also implicated
CASP8AP2/FLASH in the processing of histone pre-
mRNAs. CASP8AP2/FLASH has been detected in Cajal/
Histone locus bodies (HLB) associated with NPAT and
has been shown to functionally interact with LSM11
[24,27-30]. The most recent of these studies showed
that CASP8AP2/FLASH is required for the endonucleo-
lytic cleavage of histone pre-mRNAs [30].
It is important to note that the cRNA used in this
study was generated using an oligo dT primer, selective
for polyadenylated transcripts, and thus the changes in
the levels of the replication dependent histone tran-
scripts would appear to reflect significant alterations in
the levels of the less well defined polyadenylated ver-
sions of these histone transcripts. The detection of poly-
adenylated replication-dependent histone transcripts has
been noted previously following silencing in HeLa cells
of two other replication dependent histone 3’ end pro-
cessing proteins: negative elongation factor (NELF) and
the cap binding complex (CBC) [41]. Following silencing
of either NELF or CBC, Nariata and co-workers,
reported increases in the levels of twelve histone genes
by array analysis, also following oligo dT primer selec-
tion. Examination of the expression of two of these his-
tone genes, HIST1HC and HIST2H2AA, in detail
confirmed that this result was due to the induction of
the expression of polyadenylated transcript variants cor-
responding to these genes [41]. In SW480 cells we also
detected enhanced levels of a putative polyA HIST1HC
transcript and most of the other histone genes observed
by Narita and co-workers to express polyA variants fol-
lowing silencing of NELF or CBC (Table 1). Further,
recent next generation sequencing of RNA polyadenyla-
tion has revealed the presence of polyadenylation of
over twenty replication dependent histone mRNAs in
unperturbed HeLa cells [42]. In an unperturbed state
the polyA histone transcripts represented ~4% of the
total amount of transcription from the replication
dependent histone genes. Of the over twenty histone
transcripts with polyA variants detected by sequencing,
we detected putative polyA versions corresponding to
fifteen of these genes following CASP8AP2/FLASH LOF
(Table 1). To confirm that the CASP8AP2/FLASH LOF
leads to the induction or enhanced presence of the non-
canonical, polyadenylated transcript variants of the repli-
cation-dependent histone genes we examined by qRT-
PCR the expression of one replication-dependent
histone gene HIST1H2BD. Unlike most replication-
dependent histone genes where only the non-polyA
transcript has been annotated as having a consensus
reference sequence, two annotated transcript variants
have been reported for HIST1H2BD; NM_021063, the
non-polyA transcript variant and NM_138720 the polya-
denylated variant (Figure 5B). Using cDNA primed with
either random hexamers (Figure 5C) or oligo dT pri-
mers (Figure 5D) and primers specific for the canonical
non-polyA and the poly A transcript variants (Figure
5B) we observed that following silencing of CAPS8AP2/
FLASH (Figure 5Ci and 5Di) only the levels of the poly-
adenylated variant NM_138720 of HIST1H2BD were
increased. No significant change was seen in the levels
of the NM_021603/HIST1H2BD non-polyA variant (Fig-
ure 5Cii) when primed using random hexamers.
CASP8AP2/FLASH loss-of-function rapidly alters the
expression of the transcriptome of SW480 cells
To corroborate and extend our study of the very exten-
sive changes in expression seen following CASP8AP2/
FLASH LOF we conducted further whole transcriptome
expression assays as this platform enabled us to con-
tinue to probe in an unbiased and systematic fashion
the diverse functional consequence of silencing CAS-
P8AP2/FLASH we had observed. To further ensure the
specificity of the effects seen following CASP8AP2/
FLASH silencing we used an additional siRNA (siCAS-
P8AP2.1) and also included arrays from untransfected
SW480 cells. Importantly, to gain additional insight into
the temporal effects on the transcriptome following
CASP8AP2/FLASH LOF we assessed effects over a time
course of 10, 24, 48, and 72 hours post siRNA transfec-
tion (see Additional file 10, Figure S4 for further
details). At 72 hours all three CASP8AP2/FLASH siR-
NAs induced a significant change (Log2 > ± 0.6, q-value
< 0.05) in over 2,800 probes (~2300 genes) (Figure 6A,
Additional file 11, Table S7). Tracking the expression of
these genes over time showed many were also changed
at 48 hours, and in some cases even at 24 hours (Figure
6A, Additional file 11, Table S7). In most cases the
direction of change seen at the earlier time points were
maintained at 72 hours. All of the gene ontology cate-
gories enriched in the initial 72 hour CASP8AP2/FLASH
RNAi signature were also enriched in the follow up
study at both the 48 and 72 hour time points (Figure 6B
and Additional file 8, Table S6) further confirming the
broad but specific effects the CASP8AP2/FLASH LOF
has on SW480 cells. Using GSEA we confirmed the sig-
nificant enrichment for changes in the levels of histone
transcripts at 24, 48, and 72 hours (Figure 6C). At just
24 hours after silencing of CASP8AP2/FLASH the
majority of probes indicating a significant change in the
expression (q < 0.05) corresponded to the replication
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Figure 6 The loss of CASP8AP2/FLASH function induces consistent effects on the transcriptome of CRC cells.( A) Heat map representation
of the median fold change for those transcripts showing a significant fold change (> ± 0.6 Log2 fold change, p < 0.05) at 72 hours post-
transfection for all three siRNAs corresponding to CASP8AP2/FLASH when compared to the expression profiles obtained for siNeg transfected
SW480 cells generated at the same time points. Data at earlier time points reflects the fold changes seen for all of these transcripts, though
these changes in expression may have not reached significance. (B) The enrichment of functional ontologies for upregulated genes with the
CASP8AP2/FLASH RNAi signatures obtained 48 and 72 hours post siRNA transfection. No statistically significant enrichment was seen for genes
showing a downregulation in expression within the CASP8AP2/FLASH RNAi signature. (C) Gene set enrichment analysis of the human histone
genes at 10, 24, 48 and 72 hours. (D and E) Gene set enrichment analysis of the targets of transcription factors associated with CRC. (D) Shows
the overall statistical analysis for the enrichment of the targets within the CASP8AP2/FLASHRNAi signature for six transcription factors, (E)(i) shows
the enrichment plots for the targets of NFB over time, (ii) shows the enrichment plots for the upregulated targets of the MYC transcription
factor over time, and (iii) shows the enrichment plots for the downregulated targets of the MYC transcription factor over time.
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Page 16 of 22dependent histone proteins (Additional file 12 Table S8).
At 72 hours post CASP8AP2/FLASH siRNA transfection
we detected almost exactly the same complement of his-
tone genes showing expression of the polyA variant as
seen previously (Additional file 12, Table S8). All of the
histone genes noted by Narita and co-workers as expres-
sing polyA variants following silencing of NELF or CBC
[41] were again changed following CASP8PA2/FLASH
(Additional file 12, Table S8). Two further polyA variant
transcripts noted by Shepard and co-workers [42] were
also now detected in CASP8PA2/FLASH silenced cells
(Additional file 12, Table S8). The vast majority of the
transcripts corresponding to replication dependent his-
tones showed an increase in levels following silencing of
CASP8AP2/FLASH confirming that the inhibition of the
function of proteins required for the canonical proces-
sing of histone transcripts predominately leads to the
induction and/or accumulation of polyadenylated his-
tone transcripts. Future studies will be required to
determine the exact mechanism underlying the genera-
tion of these non-canonical transcripts. Interestingly, the
probes corresponding to a very limited number of his-
tone transcripts including HIST1H1B and HIST1H4L
consistently detected a decrease in expression (Table 1
and Additional file 12, Table S8) following silencing of
CASP8AP2/FLASH. Further studies will be needed to
investigate this, and also the effect these changes in the
expression of the replication-dependent histone genes
has on the production of the replication-dependent his-
tone proteins and thus on overall chromatin architec-
ture, however our data suggests that CASP8AP2/FLASH
LOF leads to highly reproducible and specific changes
on the transcriptome.
Complementary to our original data, NFBt r a n s c r i p -
tional targets were once again significantly enriched
within the upregulated portion of the CASP8AP2/
FLASH signature at 24, 48, and 72 hours post-silencing
(GSEA FDR q-values of 0.036, < 0.001, and < 0.001
respectively) (Figure 6D and 6Ei). We had anticipated
that the time course data could be used to identify dri-
vers of this transcriptional response, however, though
TNF-centered knowledge based networks could be gen-
erated from the CASP8AP2/FLASH RNAi signature
(Additional file 13, Figure S5) there was limited overlap
between the specific genes that formed these networks
and those obtained previously (Additional 8, Figure S3).
We also confirmed that gene targets activated by MYC
were downregulated at 24, 48, and 72 hours (all FDR q-
values of < 0.001), and genes known to be suppressed
by MYC were upregulated at the same time points
(GSEA FDR q-values of 0.014, < 0.001, and < 0.001 at
24, 48 and 72 hours respectively) (Figure 6D and 6Eii
and iii). While it is clear that transcriptional activity of
MYC is reduced, we have been unable to identify
upstream mediators that link these transcriptional
changes to CASP8AP2/FLASH loss-of-function. Further
work will thus be required to identify the specific signal-
ing processes connecting CASP8AP2/FLASH silencing to
alterations in these transcriptional networks.
All of the cyclin dependent kinase inhibitor genes
identified as upregulated following CASP8AP2/FLASH
silencing previously were once again upregulated, with
CDKN1C (p57
Kip2) once more showing the greatest
change. Forty-eight hours post CASP8AP2/FLASH silen-
cing CDKN1C/p57
Kip2 mRNA levels increased ~ 4 linear
fold, and this was further enhanced by 72 hours post
siRNA transfection when its levels were increased by
over 6 linear fold. Interestingly, one study of the expres-
sion of CDKN1C/p57
Kip2 observed decreased immunos-
taining in colorectal carcinomas [43], and in our
colorectal cell lines and tumor samples we saw signifi-
cant reduction in expression (CDKN1C/p57
Kip2 expres-
sion in CRC cell lines versus normal mucosa mean
linear = 0.17 (p < 0.00098) and primary colon tumor
versus normal mucosa mean linear ratio = 0.15 (p <
0.0026)). Altered expression of CDKN1C/p57/Kip2 has
been noted in several cancer types, frequently as a result
of epigenetic changes leading to speculation that it may
act as a tumor suppressor [44]. It will interesting to
determine in the future if any of the alterations in his-
tone gene transcription observed following the silencing
of CASP8AP2/FLASH modulates the expression of epi-
gentically regulated genes such as CDKN1C/p57
Kip2.I t
will also be important in future studies to determine if
CASP8AP2/FLASH LOF induces similar effects in other
colorectal cancer cell lines and in other cancer cell
types.
The silencing of CASP8AP2/FLASH enhances the
expression of neurofilament heavy polypeptide (NEFH)
The most significantly upregulated annotated gene fol-
lowing CASP8AP2/FLASH loss-of-function was NEFH,
which was upregulated more than 40 linear fold follow-
ing the silencing of CASP8AP2/FLASH.T h i sg e n e
encodes the neurofilament heavy polypetide (Figure 7A).
Recently, it has been shown that the NEFH gene is
methylated in esophageal squamous cell carcinoma
(ESCC) and that the inhibition of NEFH expression in
ESCC leads to activation of both the AKT and ß-cate-
nin/TCF7L2 pathways [45]. Our time course experiment
shows that the up-regulation of NEFH occurs between
24 and 48 hours after initiation of the silencing of CAS-
P8AP2/FLASH ( F i g u r e7 B ) .T oa s s e s si fC A S P 8 A P 2 /
FLASH LOF increases the level of NEFH at a protein
level we performed Western blot analysis following
silencing of CASP8AP2/FLASH (Figure 7C). Duplicate
samples were also assessed by qRT-PCR for mRNA
reduction: siCASP8AP2.3 and siCASP8AP2.6 reduced
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Page 17 of 22CASP8AP2/FLASH transcript levels by 63% and 77%,
respectively. Western blot analysis showed a clear induc-
tion of NEFH following inhibition of CASP8AP2/FLASH.
T h eg e n ee x p r e s s i o nd a t af o rNEFH for CRC cell lines
and primary tissues compared to the expression in
normal colon mucosa showed this gene is significantly
reduced in expression (Figure 7D; p < 2.1 × 10
-13 in cell
lines and p < 9.6 × 10
-13 in tumors). Given that NEFH
may function as a tumor suppressor in ESCC [45] it will
be interesting to determine if it performs a similar role
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Figure 7 Loss of function of CASP8AP2/FLASH induces expression of NEFH .( A) The expression of NEFH 72 hours following silencing of
CASP8AP2/FLASH (2 different siRNAs) as measured by microarray analysis. (B) The expression of NEFH at 10, 24, 48 and 72 hours following
silencing of CASP8AP2/FLASH (three different siRNAs) as measured by microarray analysis. (C) Western blot analysis shows increased abundance of
NEFH protein 72 hours after silencing of CASP8AP2/FLASH.( D) Molecular characteristics of NEFH in colorectal cell lines and primary tumors. (i) The
expression of NEFH mRNA in colorectal cell lines. All data is expressed as Log2 fold change from that observed in normal mucosa sample. (ii)
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Page 18 of 22in colorectal cancer. Ectopic expression of NEFH has
been linked to suppression of targets of the ß-catenin/
TCF7L2 signaling [45]. While we saw no statistically sig-
nificant evidence of repression of the ß-catenin pathway
within the CASP8AP2/FLASH RNAi signature (Figures
3C and 4D) it is should be noted that CTNNB1 tran-
script levels were somewhat reduced (~2 linear fold
change) at both 48 and 72 hours post CASP8AP2 siRNA
transfection. Also, one of the most significantly downre-
gulated genes following silencing of CASP8AP2/FLASH
was NOTUM (Exp 1: 72 hours, siCASP8AP.3, 3.1 linear
f o l dd e c r e a s e ,p=0 . 0 0 1 ;s i C A S P 8 A P . 6 ,3 . 7l i n e a rf o l d
decrease p = 0.0002; Exp. 2: median fold change 48 hrs:
3.5 linear fold decrease, p = 0.0032; 72 hrs: 4.4 linear
fold decrease, p = 0.0002). NOTUM, best characterized
in Drosophila as regulated by Wingless,h a sr e c e n t l y
been identified as a direct target of the ß-catenin/
TCF7L2 that is overexpressed in hepatocellular carci-
noma (HCC) [46]. This same study noted over expres-
sion of NOTUM in SW480 cells and in pooled sample
of three colorectal tumors. We have also observed
increased expression of NOTUM in SW480 cells (18.3-
fold increase relative to normal mucosa) and over 75%
of primary colon adenocarcinomas (18/23) showed a 2
linear fold or greater overexpression of NOTUM.
Further studies will be required, but this may suggest,
that NOTUM,a si nH C C ,i sat a r g e to ft h ef r e q u e n t l y
activated ß-catenin/TCF7L2 pathway observed in CRC.
Conclusions
We have identified Caspase-8-Associated protein 2/
FLICE-associated huge protein (CASP8AP2/FLASH) as
essential for the survival of colorectal cancer cells. Con-
trary to what would perhaps be expected given its prin-
ciple annotated function as a pro-apoptotic factor
required for activation of the extrinsic apoptotic path-
way, we observed, in the absence of FAS stimulation,
significant activation of both Caspase 8 and Caspase 3/7
following inhibition of CASP8AP2/FLASH function.
Instead, systems-wide analysis of the LOF of CAS-
P8AP2/FLASH confirmed and extended biochemical
studies showing that CASP8AP2/FLASH has a critical
role in regulating the expression of the replication-
dependent histone genes. The observation that the
expression levels CASP8AP2/FLASH are the same in
normal and colorectal cancer tissue also suggests a role
in normal homeostasis for this protein as would be
expected if its primary role is in regulating the expres-
sion of the replication-dependent histone genes. Also by
using an unbiased, whole transcriptome approach we
were able to identify that additional downstream effects
of CASP8AP2/FLASH LOF included enhanced expres-
sion of genes targeted by NFB and evidence of
decreased MYC activity. Finally, silencing of CASP8AP2/
FLASH led to expression of a recently identified tumor
suppressor gene NEFH. NEFH has been shown to be the
subject of epigenetic modification, as too has another
gene upregulated following CASP8AP2/FLASH silencing,
CDKNIC/p57. It is our current hypothesis that the
changes in the expression of these genes following silen-
cing of CASP8AP2/FLASH is likely an indirect effect; it
could be that these genes are the target of one or more
of the transcription factors that we see target enrich-
ment for within the CASP8AP2/FLASH RNAi signature,
or it may be that changes in the processing of the tran-
scripts corresponding to the replication dependent his-
tone transcripts is altering expression more broadly.
Additional material
Additional file 1: Table S1. A siRNA based RNAi screen of 418 genes
representing different functional groups associated with apoptosis. Data
is shown relative to siNegative transfected cells and is ranked
alphabetically within the following groups; both siRNAs ≥25% decrease
in cell viability, siRNA.1 ≥25% decrease in cell viability, siRNA.2 ≥25%
decrease in cell viability, both siRNAs. ≤25% decease in cell viability.
Additional file 2: Figure S1. Optimization, execution and follow up of a
siRNA based RNAi screen of genes associated with apoptosis. (A)
Confirmation of Oligofectamine (Invitrogen) transfection conditions using
CTNNB1 mRNA expression as an end-point. (B) Confirmation of cell line
number and transfection conditions using an siRNA corresponding to
PLK1 and cell viability as an end-point. (C) Summary of siRNA screening
controls. Data is shown as the viability of cells transfected by a negative
control siRNA (siNeg; mean and standard deviation of 33 wells) and a
positive control siRNA (siPLK1; mean and standard deviation of 11 wells).
On average, silencing of PLK1 induced an over 85% decrease in cell
viability. (D) Summary of screening data with gene targets ranked as
shown in Additional File 1, Table S1, both siRNAs ≥25% decrease in cell
viability, siRNA.1 ≥25% decrease in cell viability, siRNA.2 ≥25% decrease
in cell viability, both siRNAs. ≤25% decease in cell viability. Closed circles
indicate data for siRNA and open circles data for siRNA 2. (E) Two
different siRNAs corresponding to 45 genes induced a 25% or greater
reduction in the viability of SW480 cells compared to siNegative-
transfected cells. Data is expressed relative to siNegative-transfected cells;
gene targets are ranked alphabetically. Genes chosen for initial validation
are marked with *. (F) Reproducibility of the effects of silencing selected
genes identified as reducing the viability of SW480 cells. Data is shown
as the mean ± SD of three independent transfections for each siRNA
targeting the fifteen genes of interest normalized to the values from
negative control siRNA transfected cells.
Additional file 3: Table S2. The sequences of gene specific siRNAs.
Additional file 4: Table S3. The sequences of gene specific PCR primers.
Additional file 5: Table S4. Transcription factor data sets used for gene
set enrichment analysis.
Additional file 6: Figure S2. The development of a CASP8AP2/FLASH
RNAi signature in SW480 cells. (A) Correlation of the fold change in
expression seen following silencing with two different CASP8AP2/FLASH
siRNAs. Each black circle corresponds to a single probe. A red circle
indicates the probe corresponding to CASP8AP2/FLASH. There was a high
concordance between the effects mediated by both siRNAs targeting
CASP8AP2/FLASH, only two probes showed discordant changes with
respect to the direction of change in that one siRNA induced an increase
in expression, while the second siRNA induced a decrease in expression.
(B) Within the very large CASP8AP2/FLASH expression profile we identified
only one transcript (ABLIM2) that showed a potential mismatch with
both CASP8AP2 siRNAs. The probe corresponding to ABLIM2 was ranked
as the 349
th down-regulate/d probe (out of a total of 1487
downregulated probes; ranked ~Log2 -2.0 to Log2 -0.6 fold change)
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Page 19 of 22within the CASP8AP2/FLASH expression profile. As this change is likely to
have had only a minimal affect on the CASP8AP2/FLASH expression
profile as a whole the data for this gene was retained within our
subsequent analysis.
Additional file 7: Table S5. CASP8AP2/FLASH RNAi signature in SW480
cells. Probes that showed a significant fold change (> Log2 ± 0.6, q <
0.05) in CASP8AP2/FLASH silenced cells compared to siNeg transfected
SW480 cells are listed, ranked by the fold change seen in siCASP8AP2.3-
silenced cells. The probe corresponding to CASP8AP2/FLASH is
highlighted in grey. The columns show: (1) The gene sequence
reference, (2) the gene symbol, (3) the chromosomal position of the
Agilent array probe, (4) the Agilent array probe identifier, (5) fold change
siNeg vs. siCASP8AP2.3 Log2 transformed, (6) fold change siNeg vs.
siCASP8AP2.6 Log2 transformed, (7) FDR (q-value), siNeg vs. siCASP8AP2.3
and (8) FDR (q-value), siNeg vs. siCASP8AP2.6.
Additional file 8: Table S6. Significant gene ontology categories within
CASP8AP2/FLASH RNAi signatures.
Additional file 9: Figure S3. The top three knowledge-based gene
networks of genes deregulated as a consequence of silencing CASP8AP2/
FLASH were generated using Ingenuity pathway analysis tools. A
maximum of 70 molecules was used for the generation of networks.
Solid edges between gene nodes represent direct interactions and
dashed lines represent indirect interactions. Red symbols indicate
upregulated genes; Green symbols indicate downregulated genes
respectively. The number of molecules in each network is stated, as is a
score generated by IPA as an estimate of connectivity.
Additional file 10: Figure S4. The development of CASP8AP2/FLASH
RNAi signatures in SW480 cells over time. (A) Reduction in CAPS8AP2/
FLASH mRNA measured by (i) qRT-PCR and (ii) array analysis and cell
viability in SW480 cells over time. All data is normalized to the levels of
CAPS8AP2/FLASH and viability observed in siNeg transfected SW480 cells.
Correlation of the fold change in expression seen following silencing
with three different CASP8AP2/FLASH siRNAs at (B) 48 hours and (C)7 2
hours compared to siNeg transfected SW480 cells. Each black circle
corresponds to a single probe. A red circle indicates the probe
corresponding to CASP8AP2/FLASH. Using the data obtained at 48 and 72
hours we observed no off-target sequence alignments between
transcripts showing a decrease in expression for all three siRNAs and the
sequences of the three different CASP8AP2/FLASH siRNAs though nine
genes showed off-target alignments with two of three siRNAs (data not
shown). To assess the reproducibility of our initial findings we examined
the expression of genes that previously showed differential expression
following transfection of siCASP8AP2.3 and siCASP8AP2.6 siRNAs, with
data obtained at the same time point (72 hours) with same siRNAs as
part of this follow up study. The data for ~2000 probes were compared.
(D) Correlation of the fold change in expression seen in two different
experiments in which CASP8AP2/FLASH has been silenced for 72 hours.
Each black circle corresponds to a single probe.
Additional file 11: Table S7. Changes in gene expression over time
following silencing of CASP8AP2/FLASH. Data is shown for the 2820
probes that measured a significant change in expression in SW480 cells
transfected with each of the three CASP8AP2/FLASH siRNAs at 72 hours
and the data for the same probes at 48, 24 and 10 hours post siRNA
transfection. The median fold change for each probe is shown as well as
the data for each of the three siRNAs; data is ranked on the median
value at 72 hours. Fold changes ≥ Log2 -0.6 and q < 0.05 matched to
any probe showing a decreased level of expression are marked in green
and fold changes of ≥0.6 and q < 0.05 matched to any probe showing
an increased level of expression are marked in red. The probe
corresponding to CASP8AP2/FLASH is marked is highlighted in yellow.
Additional file 12: Table S8. Changes in histone transcript levels at
multiple time points following silencing of CASP8AP2/FLASH.
Additional file 13: Figure S5. TNF focused knowledge-based gene
networks of genes deregulated as following silencing of CASP8AP2/FLASH.
TNF network at (A) 48-hours, and (B) 72-hours generated using Ingenuity
pathway analysis tools. A maximum of 70 molecules was used for the
generation of networks. Solid edges between gene nodes represent
direct interactions and dashed lines represent indirect interactions. Red
symbols indicate upregulated genes; Green symbols indicate
downregulated genes respectively. The number of molecules in each
network is stated, as is a score generated by IPA as an estimate of
connectivity.
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inhibitor 1C (p57, Kip2); CRC: colorectal cancer; DEDs: death-effector
domains; DISC: Death-Inducing Signaling Complex; ESCC: esophageal
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